Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2019International Journal of Emergency MedicineOpen Access

Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature

View Full Paper
Ask AI
Bookmark
Share

Authors

ADAlexis Diaz-RamosIllinois CollegeWEWesley EilbertIllinois CollegeDMDiego MárquezNational University of Salta

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Diaz-Ramos et al. (2019) studied this question.

synapsesocial.com/papers/6a77e796d8eb58afc2be388bhttps://doi.org/10.1186/s12245-019-0240-0
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition2015 · 849 citations
  2. 2Efficacy and Safety of Canagliflozin, a Sodium–Glucose Cotransporter 2 Inhibitor, as Add-on to Insulin in Patients With Type 1 Diabetes2015 · 285 citations
  3. 3Trends in Diabetic Ketoacidosis Hospitalizations and In-Hospital Mortality — United States, 2000–20142018 · 330 citations
  4. 4Sodium-Glucose Cotransporter-2 Inhibitors in Nephrology Practice: A Narrative Review2020 · 13 citations
  5. 5SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System2017 · 237 citations